Press releases
- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
- Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
- Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
More ▼
Key statistics
As of last trade Heron Therapeutics Inc (AXD2:MUN) traded at 2.62, -18.13% below its 52-week high of 3.20, set on Jan 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.62 |
---|---|
High | 2.62 |
Low | 2.62 |
Bid | 2.65 |
Offer | 2.75 |
Previous close | 2.39 |
Average volume | 224.44 |
---|---|
Shares outstanding | 150.64m |
Free float | 149.59m |
P/E (TTM) | -- |
Market cap | 427.81m USD |
EPS (TTM) | -0.8695 USD |
Data delayed at least 15 minutes, as of May 07 2024 07:11 BST.
More ▼